Navigation Links
Bush vetoes stem cell research bill

Washington, D.C. - Calling the destruction of human embryos a line that society should not cross, President Bush has vetoed a bill that would have overturned his ban on new federal funding for human embryonic stem cell research, and an override attempt failed in the House of Representatives.

"It crosses a moral boundary that our decent......

Full article >>> le blasts veto

Following the veto, Wisconsin Gov. Jim Doyle held a conference call with state reporters. Doyle said he looked forward to the day when there will be a different president who would support additional federal funding for human embryonic stem cell research.

Doyle, appearing with Custer, Wis. resident Pam Fleishauer, wh......

Full article >>> lative affairs director. "President Bush stood tall today in the preservation of human life."

Earlier, Sande had blasted Wisconsin Senators Herb Kohl and Russ Feingold, who voted for H.R. 810.

In the House vote, the Wisconsin delegation was split along partisan lines. Voting to override the veto were Democrats Tammy Baldwin, Ron Kind, Gwen Moore, and David Obey. Joining Green in......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 07/19/06


Related biology technology :

1. Doyle vetoes cloning ban
2. Doyle partially vetoes SE Wisconsin technology grant
3. Separating hope from hype in stem-cell research
4. NimbleGen researcher to lead $415K DNA project
5. UW-Madison to receive $125M for bioenergy research center
6. Jamie Thomson to run California research lab
7. Mirus Bio secures $900K grant to develop research tool
8. UW-Madison launches new high-speed research network
9. Of private equity, research, and drug development
10. Wisconsin can offer what a federal energy research lab needs
11. UW-Madison approves new research institute
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... Corporation (NASDAQ: VWR), the leading global independent provider of product ... its financial results for the fourth quarter and full year ... 4Q16 record quarterly net sales of $1.13 billion, up ... 4Q16 EMEA-APAC segment net sales increased ... net sales increased 2.5%, or down 0.9% on an organic ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
Breaking Biology Technology:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):